The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program but also Medicaid and Medicare Part B if manufacturers implement a cash ...

Pharmaceutical company Novartis has filed a lawsuit against the HHS over the way drugs are priced under the 340B program. The company is challenging the “product replenishment model,” which requires ...

Drugmaker Eli Lilly has joined Johnson & Johnson is suing the Biden administration to try to reinstate plans that change the way the companies offer drug discounts to hospitals. Eli Lilly filed a ...